Autopsy report · NCT00843830

A Pilot Study Assessing Intra-Metastasis Administration of Autologous KLH-pulsed Dendritic Cells With Tumoral Radiation Therapy in Patients With Metastatic Pancreatic Carcinoma

“Study closed early secondary to inability to obtain grant funding to conduct.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 4 months after it had already started.
• Ran for about 3 years 6 months before it stopped.
• 4 participants enrolled.
• Results were posted on the registry 4 years 7 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

University of Michigan Rogel Cancer Center

Sponsor type

University, hospital or other

Conditions

Metastatic Pancreatic Carcinoma

Interventions

tumoral irradiation; Dendritic cell vaccination

Participants

4

Sites

1

Countries

United States

Trials that died the same way

• GO-203-2C + Bortezomib For Relapsed Or Refractory MM
  “Study was never open due to lack of funding” (75% match in meaning)
• Review and Assessment of Network Meta-analyses for Knowledge Uptake Study
  “did not receive funding to conduct study” (73% match in meaning)
• Use of Tranexamic Acid in Facial Fillers
  “Study closed prior to opening to enrollment, due to funding availability for study” (73% match in meaning)
• Study of EQU-001 for Uncontrolled Focal Onset Seizures
  “insufficient funding to complete the study” (72% match in meaning)
• Study to Determine Pediatric Bladder Volume Prior to Catheterization
  “Inability to obtain grant funding” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.